Inquiry Basket
Loading ......
Filter By Product Search for
ABLIM1
ABLIM1 Full Name
actin binding LIM protein 1
ABLIM1 Introduction
Actin-binding LIM protein 1 (ABLIM1) is a multifaceted cytoskeletal-interacting protein that plays a critical role in bridging the actin cytoskeleton with complex intracellular signaling networks. Structurally, ABLIM1 is characterized by four N-terminal zinc-binding LIM domains, a central intrinsically disordered region (IDR), and a C-terminal villin headpiece (VHP) domain. The VHP domain serves as the primary anchor for directly binding to filamentous actin (F-actin), while the LIM domains function as versatile modular scaffolds, facilitating protein-protein interactions with various cytoplasmic targets and mediating cellular responses to mechanical stimuli.
Figure 1. Dual localization of LIM proteins. (Source: Kadrmas JL, et al. 2004)
ABLIM1 is a pivotal regulator of actin dynamics, cell shape, motility, and mechanotransduction. By modulating the polymerization and cross-linking of actin filaments, it orchestrates the structural integrity of the cell cortex and regulates directional migration. Beyond its canonical structural roles, recent breakthrough research has fundamentally expanded the biological repertoire of ABLIM1, revealing that it can function as an atypical E3 ubiquitin ligase. In specific cellular contexts, ABLIM1 actively polyubiquitinates inhibitory proteins like IκBα, driving their proteasomal degradation and consequently triggering the robust activation of downstream transcriptional cascades, such as the NF-κB signaling pathway.
Clinically, the dysregulation of ABLIM1 is heavily implicated in a broad spectrum of human pathologies, characterized by an intriguing functional duality. In certain malignancies, including hepatocellular carcinoma and glioblastoma, ABLIM1 has been traditionally viewed as a tumor suppressor, where its downregulation compromises actin-dependent cell adhesion and promotes invasive phenotypes. Conversely, recent oncology studies have unmasked a potent oncogenic role for ABLIM1 in colorectal cancer (CRC). In CRC, ABLIM1 is significantly overexpressed and utilizes its newly discovered E3 ligase activity to hyperactivate the NF-κB/CCL20 axis, aggressively driving tumor proliferation and liver metastasis. Furthermore, beyond oncology, abnormal alternative splicing of the ABLIM1 gene in skeletal muscle is directly linked to the muscular pathology observed in myotonic dystrophy type 1 (DM1), highlighting its critical importance in both normal development and disease progression.
Alternate Names for ABLIM1
ABLIM1; actin binding LIM protein 1; ABLIM; LIMAB1; actin-binding LIM protein 1; abLIM; limatin; actin-binding double-zinc-finger protein; actin-binding LIM protein family member 1; ABLIM; LIMAB1; LIMATIN; abLIM-1; MGC1224; FLJ14564; KIAA0059; DKFZp781D0148;
Loading ......
